DIN 02331675 — CIMZIA 200 MG
CIMZIA is a solution of Certolizumab pegol marketed by UCB CANADA INC. The full Certolizumab pegol monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02331675
- Brand name
- CIMZIA
- Active ingredient
- Certolizumab pegol
- Strength
- 200 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- UCB CANADA INC
- Health Canada status
- MARKETED
- Drug class
- TNF-alpha inhibitor (biologic DMARD)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Certolizumab pegol products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02465574 | CIMZIA | 200 MG | SOLUTION | UCB CANADA INC | MARKETED |